The impact of pathogen burden on leukocyte telomere length in the Multi-Ethnic Study of Atherosclerosis

A E Aiello1, B Jayabalasingham2, A M Simanek3

  • 1Department of Epidemiology,Gillings School of Global Public Health, and the Carolina Population Center, The University of North Carolina at Chapel Hill,Chapel Hill, NC,USA.

Epidemiology and Infection
|September 8, 2017
PubMed

Insights

Persistent infections, particularly cytomegalovirus (CMV), are linked to shorter telomere length in women. This association was not observed in men, suggesting potential sex-specific health implications for pathogen burden and cellular aging.

Area of Science:

  • Infectious Diseases
  • Genetics
  • Epidemiology

Background:

  • Telomere shortening is associated with aging and disease.
  • Sex-specific differences in infection-related health outcomes are increasingly recognized.
  • Persistent infections may influence cellular aging processes like telomere attrition.

Purpose of the Study:

  • To investigate the association between seropositivity to common persistent pathogens and leukocyte telomere length.
  • To examine potential sex differences in these associations.
  • To assess the impact of total pathogen burden on telomere length.

Main Methods:

  • Cross-sectional analysis of data from the Multi-Ethnic Study of Atherosclerosis (N = 163).
  • Assessed seropositivity for cytomegalovirus (CMV), herpes simplex virus-1, Helicobacter pylori, and Chlamydia pneumoniae.
  • Linear regression models were used to evaluate associations between pathogen burden and telomere length, adjusting for confounders.

Main Results:

  • Cytomegalovirus (CMV) seropositivity was significantly associated with shorter telomere length in females (β = -0·1204, P = 0·044).
  • Increased total pathogen burden was also linked to shorter telomeres in females (β = -0·1057, P = 0·033).
  • No statistically significant associations were found among males.

Conclusions:

  • Persistent infections, especially CMV, may contribute to telomere shortening in women.
  • Pathogen burden could be a modifiable factor influencing cellular aging in females.
  • Further longitudinal research is warranted to confirm these sex-specific findings.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
26
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K